Chong Kun Cheon

1.4k total citations
81 papers, 865 citations indexed

About

Chong Kun Cheon is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chong Kun Cheon has authored 81 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 26 papers in Genetics and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chong Kun Cheon's work include Metabolism and Genetic Disorders (14 papers), Lysosomal Storage Disorders Research (10 papers) and Genomic variations and chromosomal abnormalities (10 papers). Chong Kun Cheon is often cited by papers focused on Metabolism and Genetic Disorders (14 papers), Lysosomal Storage Disorders Research (10 papers) and Genomic variations and chromosomal abnormalities (10 papers). Chong Kun Cheon collaborates with scholars based in South Korea, United States and Germany. Chong Kun Cheon's co-authors include Jung Min Ko, Han‐Wook Yoo, Yoo‐Mi Kim, Gu-Hwan Kim, Beom Hee Lee, Ju Young Yoon, Jin‐Ho Choi, Ja Hye Kim, Yeoun Joo Lee and Su Yung Kim and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Medicine.

In The Last Decade

Chong Kun Cheon

73 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chong Kun Cheon South Korea 18 395 384 135 119 88 81 865
Ying Jin China 15 210 0.5× 258 0.7× 127 0.9× 44 0.4× 74 0.8× 52 865
Yasuhiro Naiki Japan 16 356 0.9× 510 1.3× 279 2.1× 106 0.9× 85 1.0× 39 918
Mohamed S. Abdel‐Hamid Egypt 15 257 0.7× 495 1.3× 67 0.5× 40 0.3× 84 1.0× 97 898
Catherine DeVile United Kingdom 17 224 0.6× 274 0.7× 183 1.4× 172 1.4× 110 1.3× 36 1.1k
Martin G. Bialer United States 18 472 1.2× 547 1.4× 258 1.9× 193 1.6× 189 2.1× 34 1.3k
Toru Momoi Japan 17 218 0.6× 334 0.9× 310 2.3× 159 1.3× 107 1.2× 40 921
Yardena Tenenbaum‐Rakover Israel 20 395 1.0× 609 1.6× 537 4.0× 119 1.0× 135 1.5× 52 1.3k
Alena Musilová Czechia 15 217 0.5× 309 0.8× 125 0.9× 94 0.8× 65 0.7× 34 768
David Coman Australia 20 227 0.6× 583 1.5× 73 0.5× 129 1.1× 89 1.0× 79 1.2k
Amirreza Haghighi Canada 13 411 1.0× 407 1.1× 35 0.3× 106 0.9× 49 0.6× 25 731

Countries citing papers authored by Chong Kun Cheon

Since Specialization
Citations

This map shows the geographic impact of Chong Kun Cheon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Kun Cheon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Kun Cheon more than expected).

Fields of papers citing papers by Chong Kun Cheon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Kun Cheon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Kun Cheon. The network helps show where Chong Kun Cheon may publish in the future.

Co-authorship network of co-authors of Chong Kun Cheon

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Kun Cheon. A scholar is included among the top collaborators of Chong Kun Cheon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Kun Cheon. Chong Kun Cheon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Sangmi, Ja‐Hyun Jang, Hyung‐Doo Park, et al.. (2025). Long-term outcomes of enzyme replacement therapy from a large cohort of Korean patients with mucopolysaccharidosis IVA (Morquio A syndrome). Molecular Genetics and Metabolism Reports. 42. 101189–101189.
3.
Rivera-Romero, Octavio, Hyun Wook Chae, Maria Felicia Faienza, et al.. (2024). Healthcare professionals’ perspectives towards the digitalisation of paediatric growth hormone therapies: expert panels in Italy and Korea. Frontiers in Endocrinology. 15. 1419667–1419667.
4.
Yoon, Ju Young, et al.. (2024). The impacts of COVID-19 on childhood obesity: prevalence, contributing factors, and implications for management. Annals of Pediatric Endocrinology & Metabolism. 29(3). 174–181. 1 indexed citations
5.
Choi, Tae‐Ik, Yu‐Ri Lee, Laurie Robak, et al.. (2024). RFC2 may contribute to the pathogenicity of Williams syndrome revealed in a zebrafish model. Journal of genetics and genomics. 51(12). 1389–1403. 1 indexed citations
6.
Cheon, Chong Kun, et al.. (2024). Identification of a novel mutation of the SHOX gene in a patient with Leri-Weill dyschondrosteosis accompanied by growth hormone deficiency. Annals of Pediatric Endocrinology & Metabolism. 29(3). 201–203. 1 indexed citations
7.
Myung, Kyungjae, et al.. (2023). A heterozygous mutation in UBE2H in a patient with developmental delay leads to an aberrant brain development in zebrafish. Human Genomics. 17(1). 44–44. 4 indexed citations
8.
Yoon, Ju Young, Chong Kun Cheon, Jung Hyun Lee, et al.. (2022). Response to growth hormone according to provocation test results in idiopathic short stature and idiopathic growth hormone deficiency. Annals of Pediatric Endocrinology & Metabolism. 27(1). 37–43. 11 indexed citations
9.
Jo, Kyo Jin, Su Eun Park, Chong Kun Cheon, Seung Hwan Oh, & Seong Heon Kim. (2022). Haploinsufficiency A20 misdiagnosed as PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis) syndrome with Kikuchi disease. Clinical and Experimental Pediatrics. 66(2). 82–84. 4 indexed citations
10.
Yoon, Ju Young, et al.. (2022). The first case of novel variants of the FSHR mutation causing primary amenorrhea in 2 siblings in Korea. Annals of Pediatric Endocrinology & Metabolism. 28(1). 54–60. 3 indexed citations
11.
Yoon, Ju Young, et al.. (2021). Clinical relevance of targeted exome sequencing in patients with rare syndromic short stature. Orphanet Journal of Rare Diseases. 16(1). 297–297. 6 indexed citations
12.
Choi, Jin Ho, Young Bae Sohn, Jung Min Ko, et al.. (2020). The GBA p.G85E mutation in Korean patients with non-neuronopathic Gaucher disease: founder and neuroprotective effects. Orphanet Journal of Rare Diseases. 15(1). 318–318. 9 indexed citations
13.
Choi, Jin‐Ho, Arum Oh, Gu-Hwan Kim, et al.. (2020). Clinical, endocrinological, and molecular features of four Korean cases of cytochrome P450 oxidoreductase deficiency. Annals of Pediatric Endocrinology & Metabolism. 25(2). 97–103. 6 indexed citations
14.
Lee, Joo Young, et al.. (2020). Functional Characterization of Gomisin N in High-Fat-Induced Drosophila Obesity Models. International Journal of Molecular Sciences. 21(19). 7209–7209. 12 indexed citations
16.
Yoon, Ju Young, et al.. (2019). Genotype and Phenotype, Growth Outcome in 33 Korean Patients with 21-Hydroxylase Deficiency. 92. 1 indexed citations
17.
Cheon, Chong Kun, et al.. (2019). Short-term Treatment of Liraglutide in Patient with Prader-Willi Syndrome. 92. 1 indexed citations
18.
Lee, Yun‐Jin, et al.. (2014). Melkersson-Rosenthal Syndrome With Hashimoto Thyroiditis in a 9-Year-Old Girl: An Autoimmune Disorder. Pediatric Neurology. 50(5). 503–506. 9 indexed citations
19.
Lee, Jung Hyun, Gu-Hwan Kim, Han‐Wook Yoo, & Chong Kun Cheon. (2014). OTC Gene in Ornithine Transcarbamylase Deficiency: Clinical Course and Mutational Spectrum in Seven Korean Patients. Pediatric Neurology. 51(3). 354–359.e1. 7 indexed citations
20.
Ko, Jung Min, Jae‐Min Kim, Chong Kun Cheon, et al.. (2009). The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome. Clinical Endocrinology. 72(2). 196–202. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026